Appointments

866.320.4573

Submit a Form

Questions

800.223.2273

Submit a Form

Expand Content

A Multi-center Randomized Phase IIa Study of Human Monoclonal Antibody to IL-12p40 (CNTO 1275) in Subjects With Moderately to Severely Active Crohn's Disease  

Title: A Multi-center, Randomized, Phase IIa Study of Human Monoclonal Antibody to IL-12p40 (CNTO 1275) in Subjects With Moderately to Severely Active Crohn’s Disease
Clinical Area: Inflammatory Bowel Disease
Status: Open
Principal Name: Bret Lashner, M.D.
Contact Name: Angela
Alternate Phone: (216) 445-3852